{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:42:01Z","timestamp":1790707321838,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006146","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T00:00:00Z","timestamp":1377734400000}}],"reference-count":122,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006146.pub2","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T04:34:03Z","timestamp":1377750843000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":125,"title":["Opioids for neuropathic pain"],"prefix":"10.1002","volume":"2019","author":[{"given":"Ewan D","family":"McNicol","sequence":"first","affiliation":[{"name":"Tufts Medical Center; Department of Anesthesiology and Perioperative Medicine; Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayelet","family":"Midbari","sequence":"additional","affiliation":[{"name":"Institute of Pain Medicine; Pain Research Unit; Rambam Health Care Campus and the Technion-Israel Institute of Technology Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elon","family":"Eisenberg","sequence":"additional","affiliation":[{"name":"Rambam Health Care Campus and the Technion-Israel Institute of Technology; Pain Research Unit; Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,8,29]]},"reference":[{"key":"10.1002\/14651858.CD006146.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3959(88)90198-4","article-title":"Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain","volume":"33","author":"Arner","year":"1988","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1212\/WNL.58.4.554","article-title":"Effects of IV morphine in central pain: a randomized placebo-controlled study","volume":"58","author":"Attal","year":"2002","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(96)09024-1","article-title":"Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain","volume":"349","author":"Dellemijn","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0304-3959(94)90129-5","article-title":"Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo","volume":"58","author":"Eide","year":"1994","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1227\/00006123-199512000-00007","article-title":"Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation","volume":"37","author":"Eide","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.39429.619653.80","article-title":"Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study","volume":"336","author":"Frank","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/01.WNL.0000057720.36503.2C","article-title":"Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial","volume":"60","author":"Gimbel","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.ajp.0000173018.64741.62","article-title":"The validity of the neuropathic pain scale for assessing diabetic neuropathic pain in a clinical trial","volume":"22","author":"Jensen","year":"2006","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejpain.2007.12.010","article-title":"Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients","volume":"12","author":"Hanna","year":"2008","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1213\/00000539-200102000-00039","article-title":"The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study","volume":"92","author":"Harke","year":"2001","journal-title":"Anesthesia and Analgesia"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3959(00)00385-7","article-title":"The effect of opioids on phantom limb pain and cortical reorganization","volume":"90","author":"Huse","year":"2001","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/0140-6736(92)91194-D","article-title":"Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia","volume":"339","author":"Jadad","year":"1992","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0304-3959(02)00122-7","article-title":"Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine-a double-blind, cross-over comparison with alfentanil and placebo","volume":"101","author":"Jorum","year":"2003","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0015|cit15","first-page":"307","article-title":"Comparison of the efficacy of oxycodone plus lidocaine versus tramadol plus lidocaine in continuous infusion in relieving acute neuropathic pain","volume":"16","author":"Juarez Pichardo","year":"2009","journal-title":"Revista de la Sociedad Espanola del Dolor"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain","volume":"130","author":"Khoromi","year":"2007","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(91)90004-H","article-title":"Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain","volume":"47","author":"Kupers","year":"1991","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(91)90004-H","article-title":"Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain","volume":"47","author":"Kupers","year":"1991","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0304-3959(00)00433-4","article-title":"Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain","volume":"91","author":"Leung","year":"2001","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/clpt.1988.44","article-title":"Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo","volume":"43","author":"Max","year":"1988","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00002826-199508000-00008","article-title":"Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo","volume":"18","author":"Max","year":"1995","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1191\/0269216303pm815oa","article-title":"Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial","volume":"17","author":"Morley","year":"2003","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0023|cit23","first-page":"1060","article-title":"Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain","volume":"289","author":"Rabben","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/WNL.41.7.1024","article-title":"Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia","volume":"41","author":"Rowbotham","year":"1991","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa021420","article-title":"Oral opioid therapy for chronic peripheral and central neuropathic pain","volume":"348","author":"Rowbotham","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.clinthera.2007.04.007","article-title":"Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study","volume":"29","author":"Simpson","year":"2007","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5055\/jom.2006.0026","article-title":"A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008 - a long-acting, parenteral opioid analgesic - in the treatment of postherpetic neuralgia","volume":"2","author":"Wallace","year":"2006","journal-title":"Journal of Opioid Management"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","article-title":"Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia","volume":"50","author":"Watson","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(03)00160-X","article-title":"Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy","volume":"105","author":"Watson","year":"2003","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00000542-200204000-00010","article-title":"Analgesic effects of intravenous lidocaine and morphine on postamputation pain: a randomized double-blind, active placebo-controlled, crossover trial","volume":"96","author":"Wu","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00000542-200204000-00010","article-title":"Analgesic effects of intravenous lidocaine and morphine on postamputation pain: a randomized double-blind, active placebo-controlled, crossover trial","volume":"96","author":"Wu","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/ALN.0b013e31817f4523","article-title":"Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial","volume":"109","author":"Wu","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jpain.2009.09.003","article-title":"A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin","volume":"11","author":"Zin","year":"2010","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0035|cit35","first-page":"1330","article-title":"Pharmacological classification of intractable chronic pain (drug challenge tests)","volume":"57","author":"Arita","year":"2008","journal-title":"Japanese Journal of Anesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD006146.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3959(94)00262-D","article-title":"Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial","volume":"62","author":"Arkinstall","year":"1995","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1213\/ANE.0b013e318209d320","article-title":"The efficacy and safety of fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic pain","volume":"112","author":"Ashburn","year":"2011","journal-title":"Anesthesia and Analgesia"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3959(97)00172-3","article-title":"Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain","volume":"74","author":"Benedetti","year":"1998","journal-title":"Pain"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006146.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/s100670200031","article-title":"Buprenorphine in a transdermal therapeutic system-a new option","volume":"21","author":"Bohme","year":"2002","journal-title":"Clinical Rheumatology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"s50","DOI":"10.1016\/j.jpain.2009.01.321","article-title":"Efficacy and safety of tapentadol ER for chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study","volume":"10","author":"Buynak","year":"2009","journal-title":"Journal of Pain"},{"issue":"5-6","key":"10.1002\/14651858.CD006146.pub2-BIB0041|cit41","first-page":"275","article-title":"Comparison between the analgesic effects of buprenorphine and morphine in conscious man","volume":"37","author":"Cathelin","year":"1980","journal-title":"Anesth\u00e9sie, Analg\u00e9sie, R\u00e9animation"},{"issue":"5-6","key":"10.1002\/14651858.CD006146.pub2-BIB0042|cit42","first-page":"257","article-title":"Comparison between the analgesic effects of fentanyl and morphine in conscious man","volume":"37","author":"Cathelin","year":"1980","journal-title":"Anesth\u00e9sie, Analg\u00e9sie, R\u00e9animation"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jpain.2012.01.007","article-title":"Dose equivalence of immediate-release hydromorphone and once-daily osmotic-controlled extended-release hydromorphone: A randomized, double-blind trial incorporating a measure of assay sensitivity","volume":"13","author":"Cruciani","year":"2012","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pain.2008.12.022","article-title":"A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster","volume":"142","author":"Dworkin","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000186502","article-title":"Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study","volume":"61","author":"Gatti","year":"2009","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0046|cit46","first-page":"255","article-title":"Effectiveness of transdermal fentanyl combined with clodine for pain control of acute herpes zoster","volume":"29","author":"Guo","year":"2007","journal-title":"Journal of Dalian Medical University"},{"issue":"2","key":"10.1002\/14651858.CD006146.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpain.2004.05.006","article-title":"Intravenous opioid testing in patients with chronic non-cancer pain","volume":"9","author":"Gustorff","year":"2005","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.jpain.2009.01.267","article-title":"A randomized, double-blind study of OROS\u00ae hydromorphone extended release compared to placebo in opioid-tolerant patients with moderate-to-severe chronic low back pain","volume":"10","author":"Hale","year":"2009","journal-title":"Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD006146.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3959(01)00455-9","article-title":"Analgesic effects of dextromethorphan and morphine in patients with chronic pain","volume":"96","author":"Heiskanen","year":"2002","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/eujp.2001.0307","article-title":"Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with IV morphine","volume":"6","author":"Kalman","year":"2002","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1741-7015-5-39","article-title":"Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine","volume":"5","author":"Kalso","year":"2007","journal-title":"BMC Medicine"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD006146.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0885-3924(99)00129-3","article-title":"MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients","volume":"19","author":"Katz","year":"2000","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1563-258X.2003.02120.x","article-title":"Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain","volume":"153","author":"Likar","year":"2003","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3959(02)00020-9","article-title":"Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain-results of a double-blind placebo-controlled trial (MONTAS)","volume":"97","author":"Maier","year":"2002","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD006146.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3940(02)01388-5","article-title":"A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain","volume":"338","author":"McCleane","year":"2003","journal-title":"Neuroscience Letters"},{"issue":"9","key":"10.1002\/14651858.CD006146.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2044.1992.tb03253.x","article-title":"Opioid sensitivity of chronic pain: a patient-controlled analgesia method","volume":"47","author":"McQuay","year":"1992","journal-title":"Anaesthesia"},{"issue":"7","key":"10.1002\/14651858.CD006146.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/j.1552-4604.1981.tb01774.x","article-title":"Multidose\/observational, comparative clinical analgetic evaluation of buprenorphine","volume":"21","author":"Mok","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0058|cit58","first-page":"S8: 31-5","article-title":"The effect of treatment with fentanyl patches on pain relief and improvement in overall daily functioning in patients with postherpetic neuralgia","volume":"60","author":"Mordarski","year":"2009","journal-title":"Journal of Physiology and Pharmacology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1185\/030079906X89784","article-title":"Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules","volume":"22","author":"Nicholson","year":"2006","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1185\/030079906X115603","article-title":"Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain","volume":"22","author":"Nicholson","year":"2006","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/ALN.0b013e31822fd03a","article-title":"Offset analgesia in neuropathic pain patients and effect of treatment with morphine and ketamine","volume":"115","author":"Niesters","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0062|cit62","first-page":"330","article-title":"The efficacy and tolerability of tapentadol Immediate Release (IR) Versus Oxycodone IR for moderate to severe acute low back pain with radicular leg pain","volume":"13","author":"Oh","year":"2012","journal-title":"Pain Medicine"},{"issue":"7","key":"10.1002\/14651858.CD006146.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0149-2918(00)80060-0","article-title":"Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain","volume":"22","author":"Palangio","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD006146.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/030006058201000604","article-title":"A double-blind comparison of meptazinol and placebo in patients with acute and chronic pain presenting to the general practitioner","volume":"10","author":"Parker","year":"1982","journal-title":"Journal of International Medical Research"},{"issue":"8","key":"10.1002\/14651858.CD006146.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s002280050675","article-title":"Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continus","volume":"55","author":"Peat","year":"1999","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.jpain.2009.01.203","article-title":"Randomized clinical trial of the safety and efficacy of oxymorphone extended release for degenerative disc disease in opioid-naive patients","volume":"10","author":"Podolsky","year":"2009","journal-title":"Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD006146.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1185\/03007998209109758","article-title":"Double-blind comparison of meptazinol (200 mg) and dextropropoxyphene \/ paracetamol in a multi-centre, general practice setting","volume":"8","author":"Price","year":"1982","journal-title":"Current Medical Research and Opinion"},{"issue":"4","key":"10.1002\/14651858.CD006146.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0885-3924(98)00369-8","article-title":"Efficacy of analgesics in chronic pain: a series of N-of-1 studies","volume":"15","author":"Sheather-Reid","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD006146.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0149-2918(03)90019-1","article-title":"Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"25","author":"Sittl","year":"2003","journal-title":"Clinical Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD006146.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.clinthera.2004.11.008","article-title":"Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study","volume":"26","author":"Sorge","year":"2004","journal-title":"Clinical Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD006146.pub2-BIB0071|cit71","first-page":"1334","article-title":"Experience with suprofen for acute and chronic pain in neurologic practice","volume":"33","author":"Vargha von Szeged","year":"1983","journal-title":"Arzneimittelforschung"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0072|cit72","first-page":"S87","article-title":"Fentanyl buccal tablet vs immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic pain","volume":"5","author":"Varrassi","year":"2011","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jpainsymman.2010.05.004","article-title":"Long-term safety and efficacy of morphine sulfate and naltrexone hydrochloride extended release capsules, a novel formulation containing morphine and sequestered naltrexone, in patients with chronic, moderate to severe pain","volume":"40","author":"Webster","year":"2010","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"P62","DOI":"10.1016\/j.jpain.2011.02.251","article-title":"Functioning\/satisfaction with fentanyl buccal tablet compared to traditional short-acting opioids for the management of breakthrough pain in opioid-tolerant patients with chronic pain","volume":"12","author":"Webster","year":"2011","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5055\/jom.2009.0005","article-title":"Factors affecting dosing regimens of morphine sulfate extended-release (KADIAN) capsules","volume":"5","author":"Weil","year":"2009","journal-title":"Journal of Opioid Management"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0076|cit76","first-page":"45","article-title":"Controlled-release oxycodone -- a therapeutic option for severe neuropathic pain","volume":"145","author":"Worz","year":"2003","journal-title":"MMW Fortschritte der Medizin"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1526-4637.2011.01274.x","article-title":"Sustained-release oxycodone tablets for moderate to severe painful diabetic peripheral neuropathy: a multicenter, open-labeled, postmarketing clinical observation","volume":"13","author":"Yao","year":"2012","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0082|cit82","unstructured":"Breivik H Bond MJ Why pain control matters in a world full of killer diseases www.iasp-pain.org\/PCU04-4.pdf"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJM200306263482617","article-title":"Chronic neuropathic pain","volume":"348","author":"Canavero","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0086|cit86","article-title":"Chapter 9: Analysing data and undertaking meta-analyses","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions 5.1","author":"Deeks","year":"2011"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0304-3959(98)00256-5","article-title":"Are opioids effective in relieving neuropathic pain?","volume":"80","author":"Dellemijn","year":"1999","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD006146.pub2-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003726.pub3","article-title":"Tramadol for neuropathic pain","author":"Duehmke","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0885-3924(95)00165-4","article-title":"Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases","volume":"11","author":"Dunbar","year":"1996","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"83","author":"Dworkin","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain","volume":"150","author":"Finnerup","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","article-title":"Opioid dose and drug-related mortality in patients with nonmalignant pain","volume":"171","author":"Gomes","year":"2011","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in metaanalyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0096|cit96","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1212\/01.wnl.0000259085.61898.9e","article-title":"The impact of neuropathic pain on health-related quality of life: review and implications","volume":"68","author":"Jensen","year":"2007","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pain.2010.05.002","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes","volume":"150","author":"Maier","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.36076\/ppj.2008\/11\/S63","article-title":"Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids","volume":"11","author":"Manchikanti","year":"2008","journal-title":"Pain Physician"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-6576.1997.tb04634.x","article-title":"Opioid use in chronic pain","volume":"41","author":"McQuay","year":"1997","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/eujp.2001.0259","article-title":"Peripheral neuropathic pain - a multidimensional burden for patients","volume":"5","author":"Meyer-Rosberg","year":"2001","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"7","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006146.pub2-BIB0106|cit106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: Imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"Canadian Pain Society. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Research and Management"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1212\/WNL.62.5_suppl_2.S30","article-title":"Evaluation and treatment of central pain syndromes","volume":"62 (Suppl 2)","author":"Nicholson","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: an overview of recent guidelines","volume":"122","author":"O'Connor","year":"2009","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","article-title":"Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone)","volume":"8","author":"Pergolizzi","year":"2008","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/AJP.0b013e3181d1059d","article-title":"Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment","volume":"26","author":"Rhodin","year":"2010","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"ES67","DOI":"10.36076\/ppj.2012\/15\/ES67","article-title":"Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse","volume":"15","author":"Sehgal","year":"2012","journal-title":"Pain Physician"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpain.2004.10.006","article-title":"Ethical challenges in the management of chronic nonmalignant pain: negotiating through the cloud of doubt","volume":"6","author":"Sullivan","year":"2005","journal-title":"Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11916-010-0171-1","article-title":"Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon?","volume":"15","author":"Tompkin","year":"2011","journal-title":"Current Pain and Headache Reports"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression: a review","volume":"11","author":"Vallejo","year":"2004","journal-title":"American Journal of Therapeutics"},{"key":"10.1002\/14651858.CD006146.pub2-BIB0120|cit120","volume-title":"Pain management: Evidence, outcomes and quality of life. A sourcebook","author":"Wittink","year":"2005"},{"issue":"24","key":"10.1002\/14651858.CD006146.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1001\/jama.293.24.3043","article-title":"Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials","volume":"293","author":"Eisenberg","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD006146.pub2-BIB0122|cit122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006146","article-title":"Opioids for neuropathic pain","author":"Eisenberg","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006146.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:52:14Z","timestamp":1681710734000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006146.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,29]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006146.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,29]]}}}